Pacemaker, Risk Score, TAVI
Conditions
Keywords
Transcatheter aortic valve replacement, Aortic stenosis, Pacemaker implantation, Risk Score, Electrocardiogram, Risk Stratification
Brief summary
The need for permanent pacemaker implantation (PPMI) remains one of the most frequent complications after transcatheter aortic valve implantation (TAVI). This study aimed to develop a novel, two-step risk score to predict PPMI probability after TAVI and to implement it into a user-friendly website. Our risk score addresses the gap in existing data on current prosthesis generations and provides a new and clinically motivated approach to calculating the risk for PPMI.
Interventions
DEVICETAVI, pacemaker
Retrospective analysis of need for pacemaker implantation after TAVI
Sponsors
German Heart Institute
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
51 Years to 95 Years
Healthy volunteers
No
Inclusion criteria
* Patients undergoing TAVI at Deutsches Herzzentrum der Charité between January 2019 and December 2020
Exclusion criteria
* previous device implantation * valve-in-valve procedure * patients who had received an ALLEGRATM valve (NVT AG, Morges, Switzerland), a LOTUS EdgeTM valve (Boston, Scientific, Natick, Massachusetts), or a CENTERATM valve (Edwards Lifesciences, Irvine, California)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pacemaker Implantation | 30 days after TAVI | Rate of pacemaker implantation up to 30 days after TAVI according to current guidelines |
Countries
Germany
Outcome results
None listed